Carolin Häussler

Inter-Firm Collaboration

Valuation, Contracting, and Firm Restructuring

• Broschiertes Buch

Produktbeschreibung

Carolin Häussler analyzes the following topics: Do inter-firm collaborations increase firm value? Does value enhancement vary according to firm and collaboration characteristics? What determines the allocation of control rights between asymmetrical partners? Does the contractual structure influence the success of collaboration? Is collaboration supporting firm restructuring in times of change?

---

The increasing number of inter-firm collaborations suggests that the collaborative mode of organizing transactions has become quite attractive in many industries. Today's firms increasingly operate in highly technology-and knowledge intensive areas where the sources of knowledge are located more diffusely. Moreover, globalization exposes firms to global competition, but also creates tremendous opportunities for exploiting technologies and competencies more fully than in the past. Carolin Haussler's dissertation acknowledges these new challenges and studies various aspects of collaborative arrangements. Among the questions addressed in her thesis are: Do inter-firm collaboration increase firm value? How do partners in a business alliance allocate control rights? Does contractual structure influence performance? Does the collaborative mode of organizing influence firm dynamics? In her dissertation, Carolin Haussler attempts to answer some of these questions. She uses quantitative econometric evidence and qualitative information from firms. In chapter 2, she presents an event study and analyzes stock market reactions to inter-firm collaboration announcements. The findings suggest that not all firms profit equally from inter firm collaboration. In chapter 3, Carolin Haussler addresses the problems emerging in asymmetrical partnerships, e.g. between large pharmaceutical firms and biotechnology startups. Using a unique dataset on inter-firm collaborations, Haussler finds that the assignment of control rights is mainly related to incentive issues and the bargaining position of firms.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Innovation und Entrepreneurship
• Verlag: Deutscher Universitätsverlag / Gabler
• Artikelnr. des Verlages: 978-3-8244-8333-4
• 2005
• Seitenzahl: 156
• Erscheinungstermin: 25. Oktober 2005
• Englisch
• Abmessung: 210mm x 148mm x 9mm
• Gewicht: 238g
• ISBN-13: 9783824483334
• ISBN-10: 3824483335
• Artikelnr.: 14509145

Autorenporträt

Dr. Carolin Häussler ist wissenschaftliche Assistentin von Prof. Dietmar Harhoff, Ph.D., am Institut für Innovationsforschung, Technologiemanagement und Entrepreneurship der Universität München.

Inhaltsangabe

1 General introduction.- 1.1 Relevance and incidence of inter-firm collaboration.- 1.2 Definition of inter-firm collaboration.- 1.3 Contributions of this thesis.- 2 Inter-firm collaboration and firm value.- 2.1 Introduction and motivation.- 2.2 Inter-firm collaborations as value-creating mechanisms.- 2.3 Research design.- 2.4 Empirical tests and results.- 2.5 Conclusion and limitations.- 3 Control rights and the performance of asymmetrical inter-firm collaborations.- 3.1 Introduction and motivation.- 3.2 Institutional and theoretical considerations.- 3.3 Characteristics of inter-firm collaboration in biotechnology.- 3.4 Hypotheses.- 3.5 Research design.- 3.6 Empirical tests and results.- 3.7 Conclusion and limitations.- 4 Firm-specific factors and their impact on firm restructuring in times of change.- 4.1 Introduction and motivation.- 4.2 Previous industry level and firm level studies on restructuring.- 4.3 Biotechnology sector in restructuring.- 4.4 Biotechnology firm scenarios, determinants and research hypotheses.- 4.5 Research design.- 4.6 Empirical tests and results.- 4.7 Discussion and conclusion.- A Appendix of Chapter 2.- A.1: Number of ad hoc news in the German market (1997-2002).- A.2: Correlation matrix of dependent and metric independent variables.- A.3: Descriptive statistics of control variables.- B Appendix of Chapter 3.- B.1: Drug development time and stages.- B.2: Industry experts in interview series.- B.3: Questionnaire.- B.4: Co-allocation patterns of control rights.